CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Can Immunic (IMUX) Climb 163.03% to Reach the Level Wall Street Analysts Expect?

Neutral
AI Analysis

Summary

Article discusses Wall Street analyst price targets for Immunic (IMUX) with a potential upside of 163.03%. No specific clinical, regulatory, or financial catalysts are detailed in the provided text.

Importance:2/10
Sentiment:
0.00
valuationanalyst_targetstock_price
Related Companies

Read the original article

Published by yahoo_finance on August 13, 2026 1:55 PM

Read Original